Alleviating Geriatric Inpatients' Medication-related Iatrogenesis

This study will evaluate the MedWise Risk Score™ (MWRS™), a holistic approach to quantifying the risk of a patient's medication regimen. High risk patients will be identified at hospital discharge. Targeted interventions will be made to reduce their MWRS™ with a 30-day follow up. The hypothesis being tested is that a reduction in MWRS™ will lead to reduced 30-day readmission.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Iatrogenic Disease Behavior Disease Attributes Pathologic Processes Pathological Conditions, Signs and Symptoms Risk Reduction Risk Reduction Behavior

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Robert Wood Johnson University Hospital Somerset

Somerville, New Jersey, 08876, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Hospital admission for at least 48 hours
Prescribed at least 5 medications at hospital discharge
Baseline medication risk score of 20 or more

Exclusion criteria

Reside greater than 25 miles from the index facility
Discharge to hospice
Discharge against medical advice
Patient expiration during initial hospitalization

Treatment and study plan

Risk score based intervention

Other

Targeted interventions based off of risk score software

Primary outcomes

Number of individuals with an emergency department visit or hospital readmission

Time frame: 30 days after hospital discharge

Number of individuals with an emergency department visit or hospital readmission

Secondary outcomes

Difference in score between patients aged older and younger than 65 years

Time frame: At time of intervention

Comparison between age groups

Sponsors and collaborators

Lead sponsor

Rutgers, The State University of New Jersey

Other

Registry information

Acronym: AGING

Important dates

Study start: 2021
Primary completion: 2023
Study completion: 2023
First posted: Aug 24, 2021
Registry last updated: Nov 14, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed